ACP guidance aligns with FDA label updates, prompting the Senate to hold hearings on the changes.
1 report, 1 independent
Updated Oct 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ACP guidance aligns with FDA label updates, prompting the Senate to hold hearings on the changes.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
American College of Physicians
American medical-specialty organization
Nothing else this week.
-
senate
type of legislative body, often the upper house or chamber of a bicameral legislature
Related events
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- Discussion on the limits of pharmacotherapy and the role of FDA approvals.
- Donald Trump instructed the FDA to accelerate the drug review process.
- FDA removed broad black box warnings on Hormone Replacement Therapy (HRT) on November 2, 2026.